← Back to Search

Other

Miebo treatment for Dry Eye Syndrome

Phase 4
Recruiting
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up (day 7 ± 1 day)
Awards & highlights

Study Summary

This trial aims to assess the effectiveness of Miebo™ in treating dry eye disease in a real-world setting.

Who is the study for?
This trial is for individuals with Dry Eye Disease. Specific eligibility criteria are not provided, but typically participants should have a diagnosis of the condition being studied and meet other health requirements set by the study.Check my eligibility
What is being tested?
The trial is testing Miebo™, an intervention for Dry Eye Disease. It's an open-label, multicenter study which means everyone knows what treatment they're getting and it's conducted at multiple locations.See study design
What are the potential side effects?
Potential side effects of Miebo™ are not listed here, but common side effects for dry eye treatments can include eye irritation or burning, blurred vision, and discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~(day 7 ± 1 day)
This trial's timeline: 3 weeks for screening, Varies for treatment, and (day 7 ± 1 day) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean change from baseline (CFB) in dry eye symptom severity at Visit 3

Trial Design

1Treatment groups
Experimental Treatment
Group I: Miebo treatmentExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Miebo
2023
Completed Phase 4
~50

Find a Location

Who is running the clinical trial?

Bausch & Lomb IncorporatedLead Sponsor
251 Previous Clinical Trials
57,319 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit for patient enrollment in this medical study?

"The study necessitates enrolling 100 eligible individuals. Bausch & Lomb Incorporated, the sponsor, will oversee operations from diverse sites such as Site 205 situated in Petaluma, California and Site 203 located in Pittsburg, Kansas."

Answered by AI

Are there any vacancies available for patients to participate in this trial?

"Yes, data on clinicaltrials.gov indicates that this investigation is currently in search of suitable participants. The trial was initially listed on February 28, 2024 and the latest update was made on March 7, 2024. A total of 100 individuals are sought across five designated sites for enrollment."

Answered by AI

In how many medical facilities within the state is this research being conducted?

"There are 5 active sites participating in this research, including Site 205 in Petaluma, Site 203 in Pittsburg, and Site 204 in Stillwater. Additionally, there are locations at five other undisclosed places."

Answered by AI

Has the Miebo therapy been officially sanctioned by the FDA?

"Our team at Power rates the safety of Miebo treatment as a 3 on our scale, reflecting its approval status in this Phase 4 trial."

Answered by AI

Who else is applying?

What site did they apply to?
Site 202
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I’ve tried several drugs that do not work. Dry eyes is a painful and problematic condition for me.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
2024. "A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06309953.
All > Kansas City > Paid Studies Minneapolis
~25 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top